Dr Lyon studied Medicine at Oxford University where he took a 1st Class degree in Physiological Sciences in 1995, achieving second place in the final honours school. After qualifying from the John Radcliffe Medical School in 1998, he trained as a junior doctor in Cardiology in Oxford, the Royal Brompton Hospital and Sydney, Australia.
His clinical interests are in the field of heart failure, chemotherapy cardiomyopathy and Takotsubo cardiomyopathy, and he is the theme leader for heart failure research in the NIHR-funded Biomedical Research Unit at the Royal Brompton Hospital.
His main research interests include abnormal calcium physiology in heart failure, biological therapies for heart failure – these include gene therapy, stem cell therapy and myocardial tissue engineering and Takotsubo Cardiomyopathy and the influence of stress and high catecholamine levels on cardiac function.
Recent academic awards include the inaugural Bernard and Joan Marshall Young Investigator Prize from the British Society for Cardiovascular Research in 2010 and the British Cardiovascular Society Young Investigator Competition Winner (Basic Sciences) in 2009.
He has presented at numerous national and international meetings in the field of cardiac calcium pathophysiology and gene therapy in heart failure, mitochondrial function in heart failure, and Takotsubo Cardiomyopathy.
He has raised over £3m in scientifc research funding and published research papers in the myocardial biology of heart failure relating to his research interests.